DENVER -- (BUSINESS WIRE) -- Sapheneia, Inc., an American-based, global medical imaging services and technologies company, is forecasting strong sales through the end of 2013. Sapheneia was founded in 2006 and is the first non-Original Equipment Manufacturer (OEM) company created and dedicated to radiation dose reduction through image quality enhancement.
“We have multiple new product launches scheduled for this Fall in the lead up to the RSNA show (Booth 8521),” stated Paul Stashick, CEO of Sapheneia, Inc. “We’ve also just executed two major Ultrasound OEM contracts and expect a strong finish to 2013 to provide the foundation for continued growth into the 2014 fiscal year. In particular, as the Obama health care plan ramps up, our products are perfectly aligned to reduce cost, deliver better outcomes and improve the safety for patients and healthcare professionals.”
Stashick also noted that a series of recent press releases by a small European OEM competitor provided misleading and overreaching information regarding Sapheneia’s corporate solvency. Sapheneia’s full product line is completely available to customers worldwide. Sapheneia, Inc. is the owner of the intellectual property and all Clarity™ product lines, including the new Clarity™ CT PLUS to be released later this Fall.
ABOUT SAPHENEIA, INC.
Sapheneia, Inc. (“Sapheneia”) is an American global imaging services and scientific based technologies company that specializes in diagnostic and analytical image processing solutions among other innovative products. The solutions provided by Sapheneia range from dose reduction services for X-Ray and CT to improved MRI workflow. Sapheneia was founded in 2006 and utilizes the best imaging engineering worldwide through its Swedish office. It is the first non-Original Equipment Manufacturer (OEM) company created and dedicated to radiation dose reduction through image quality enhancement. Sapheneia provides medical image optimization products that promote higher diagnostic confidence, greater patient and medical staff safety, and improves medical imaging cost effectiveness. For more information visit www.sapheneia.com.